Showing results (191-200 of 229) with videos related to
Sort By:
Pageof 23
Cell Reports|November 30, 2022
Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer's diseaseJielin Xu, Chengsheng Mao, Yuan Hou, et al.Nucleic Acids Research|January 25, 2013
Development of bis-locked nucleic acid (bisLNA) oligonucleotides for efficient invasion of supercoiled duplex DNAPedro M D Moreno, Sylvain Geny, Y Vladimir Pabon, et al.Nature Chemical Biology|June 19, 2009
A crowdsourcing evaluation of the NIH chemical probesTudor I Oprea, Cristian G Bologa, Scott Boyer, et al.Cell Chemical Biology|November 11, 2019
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic SignalingChetana M Revankar, Cristian G Bologa, Richard A Pepermans, et al.Current Biology : CB|June 12, 2010
Modulation of bitter taste perception by a small molecule hTAS2R antagonistJay P Slack, Anne Brockhoff, Claudia Batram, et al.Nature Chemical Biology|May 12, 2009
In vivo effects of a GPR30 antagonistMegan K Dennis, Ritwik Burai, Chinnasamy Ramesh, et al.Chemical Society Reviews|May 23, 2020
Correction: QSAR without bordersEugene N Muratov, Jürgen Bajorath, Robert P Sheridan, et al.Oncotarget|April 13, 2018
Proteomic analysis defines kinase taxonomies specific for subtypes of breast cancerKyla A L Collins, Timothy J Stuhlmiller, Jon S Zawistowski, et al.Nucleic Acids Research|December 12, 2025
Medicines, Diseases, Indications, and Contraindications (MeDIC): a foundational resource to support drug repurposingMarcello DeLuca, Nico Matentzoglu, Elliott Sharp, et al.Molecular Cancer Therapeutics|November 9, 2007
Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgenEric A Ariazi, Andrei Leitão, Tudor I Oprea, et al.Pageof 23